India Glycols Limited · NSE:INDIAGLYCO
India Glycols — Q2 FY2022-23 Earnings Presentation
32 slides from India Glycols's earnings presentation, Nov 14, 2022
Slide 1: Stock exchange cover letter on investor presentation
14th November, 2022 The Manager (Listing) The Manager (Listing) BSE Limited National Stock Exchange of India Limited 1st Floor, New Trading Ring, Exchange Plaza, C-1, Block G, Rotunda Building, P.J. Towers, Bandra Kurla Complex, Dalal Street, Bandra (East) Mumbai – 400 001 Mumbai – 400 051 Scrip Cod
Slide 2: India Glycols Limited Investor Presentation Q2 FY 2022-23
India Glycols Limited Investor Presentation Q2 FY 2022-23
Slide 3: Safe Harbour Statement
Safe Harbour Statement This presentation and the following discussion may contain “forward looking statements” by India Glycols Limited (“IGL” or the company) that are not historical in nature. These forward looking statements, which may include statements relating to future results of operations, f
Slide 4: Q2FY23 Performance
Q2FY23 Performance INDIA GLYCOLS LIMITED
Slide 5: Performance Overview – Q2FY23 vs Q2FY22
Performance Overview – Q2FY23 vs Q2FY22 Gross Turnover Net Turnover 1,634 Cr 670 Cr - 3.6% -14.1% EBITDA EBIDTA Margin 74 Cr 11.0% - 0.6% 151 bps • Continued Feedstock, Energy and Freight headwinds • Improved EBITDA margin % 4
Slide 6: Performance Overview – H1FY23 vs H1FY22
Performance Overview – H1FY23 vs H1FY22 Gross Turnover Net Turnover 3,502 Cr 1,478 Cr 4.6% 3.3% EBITDA EBIDTA Margin 143 Cr 9.6% 9.2% 50 bps • Impact of EOD business transferred to JV • Continued Feedstock, Energy and Freight headwinds 5
Slide 7: Highlights – Q2FY23
Highlights – Q2FY23 Business Performance □ Q2 – Revenue down by 14% but EBITDA maintained – marginally down by 0.6%. Improved Bio-based EBITDA margins of 11% Specialties □ H1 – Revenue up by 3.3% and EBITDA up by 9.2%, EBITDA margin of 9.6% & Performance Chemicals □ Excellent growth in Ennature Biop
Slide 8: Commodity Prices Trends
Commodity Prices Trends Indexed as per the prices in April 2022 109% 59% 32% 58% Coal Ethanol Mild Steel Acetic Acid 159 209 149 152 136 132 100 137 122 177 113 118 108 79 155 100 74 100 124 109 55 100 48 42 Q1-2021 Q2-2021 Q3-2021 Q4-2021 Q1-2022 Q2-2022 Q1-2021 Q2-2021 Q3-2021 Q4-2021 Q1-2022 Q2-2
Slide 9: Update - International Container Freights
Update - International Container Freights Drewry World Container Index ( $ per 40 ft. container) • Sharp increase ~ 5 x in international container freight followed by a major correction • Port congestions, disruptions, container shortages easing • Softer global economic conditions – slow down, shift
Slide 10: Business Segment Highlights
Business Segment Highlights Bio-based Specialities and Performance Potable Spirits Ennature Biopharma Chemicals □ Q2 revenue down by 19.8 %, EBIT down by □ Q2- revenue down by 5%, EBIT up by 2.2% □ Revenue up by 19.2%, EBIT up by 24.9%, 14.4% compared to prior year compared to prior year □ H1 revenu
Slide 11: Financial Summary - Consolidated
Financial Summary - Consolidated Particulars (In INR Cr) Q2FY23 Q2FY22 Y-o-Y (%) Q1FY23 Q-o-Q (%) H1FY23 H1FY22 Y-o-Y (%) Revenue from operations (net of excise) 670 780 (14.1%) 808 (17.1%) 1,478 1,431 3.3% Other Income 6 8 (25.4%) 6 1.5% 12 10 27.9% Total Income 676 789 (14.3%) 814 (17.0%) 1,490 1,
Slide 12: Segment Performance - Consolidated
Segment Performance - Consolidated (In INR Cr) Q2FY23 Q2FY22 % YoY Q1FY22 % QoQ H1FY23 H1FY22 % YoY 8% 6% Bio-based Specialities and Performance Chemicals (BSPC) 23% Net 442 552 (19.8%) 549 (19.4%) 991 1,009 (1.8%) 26% Revenue 66% 71% EBIT 28 33 (14.4%) 24 19.0% 52 53 (0.9%) % margin 6.4% 6.0% 41 bp
Slide 13: Company Overview
Company Overview INDIA GLYCOLS LIMITED
Slide 14: IGL at a Glance
IGL at a Glance Go Green Diversified product portfolio Global Standards with inherent synergies Compliance with stringent global 1st in the world to use Innovative Green Technologies to manufacture Bio-based Specialties, Bio-Polymers, standards of plant operations, bio-based ethylene oxide & Potable
Slide 15: Key Milestones
Key Milestones New Grain based Ethanol plants started trail production Gorakhpur Glycol E 2 Distillery CL Textile Formulation JV Sulphation Clariant Thiocolchicoside First Bio-polymers MEG Dehradun US Nicotine Distillery EO Purification Green Solvents ENA 600 TPD Ennature Subsidiary Expansion 1988 1
Slide 16: Portfolio Leading in Bio-based Ingredients and Performance Chemicals
Portfolio Leading in Bio-based Ingredients and Performance Chemicals Bio-based Specialities Segments And Performance Potable Spirits (PS) Ennature Biopharma Chemicals (BSPC) Revenue Mix Net revenue share : 66% Net revenue share : 26% Net revenue share : 8% (Consol. Q2FY23) □ Bio-based Glycols (MEG,
Slide 17: JV with Clariant: Leaders in bio-based ethoxylates and derivatives
JV with Clariant: Leaders in in bio-based ethoxylates and derivatives Promoters Public 1 - Shareholding Combining production and distribution capacity, as 61.01% 1 38.99% 1 on 30th June 2021 the joint venture is expected to become a leading supplier of renewable materials to the rapidly growing FY20
Slide 18: Leveraging synergies to create value–integrated manufacturing for bio-based products
Leveraging synergies to create value–integrated manufacturing for bio-based products Portable Spirits (PS) Products Potable Spirit Industrial Gas ENA Power Alcohol O2, N2, Ar Brands Division Ind Gr. CO2 Grain O2 ASU EO-CO2 mix Business transferred to JV with Clariant Bio-based Specialities Green And
Slide 19: Manufacturing Capabilities
Manufacturing Capabilities Kashipur Gorakhpur Dehradun 56-acre state of art distillation 300-acre state of art integrated manufacturing complex 160,000 sq. feet state of art facility and bottling complex Grain based Ethanol with 180 KLPD Grain based Ethanol with 110 High Purity Extraction Fermentati
Slide 20: R&D: Creating value through New Product Development
R&D: Creating value through New Product Development; focus on Green Chemistry 1 Focus on NPD, designing products for the future in collaboration with our reputed customers 2 DSIR Recognized R&D at Dehradun and Kashipur 3 Exploiting available feed stocks of Bio-Alcohol, Smart Alcohol, Ethylene Oxide,
Slide 21: Business Segments
Business Segments
Slide 22: Bio-based Specialities and Performance Chemicals (BSPC)
Bio-based Specialities and Performance Chemicals (BSPC) First in the world to manufacture ethylene oxide and glycols from bio-based feedstocks e.g. Molasses, Grain Largest manufacturer of Bio-based glycols and Bio-based Ethylene Oxide made from renewable feedstock i.e. Molasses Products for a
Slide 23: Potable Spirits
Potable Spirits License for operations and sale of Country Liquor in the States of Uttar Pradesh and Uttarakhand. Also operates and sells Indian Made Foreign Liquor (“IMFL”) from its own unit and few tie-up units Company brands are available in the states of Uttarakhand, Uttar Pradesh, Delhi and
Slide 24: Ennature Biopharma
Ennature Biopharma Operates in the space of Nutraceuticals, Phytochemicals & health supplement ingredients. One of the leaders in Complex phytochemicals chemistry in India Global leader in Thiocolchicoside, a highly potent muscle relaxant API Advanced production capabilities, including organic
Slide 25: IGL - Catering to diverse end markets
IGL - Catering to diverse end markets • Glycols are used for the manufacture of polyester yarn, fibre, film and resin and as an automobile coolant • Bio-glycols cater to the beverage and food industry's packaging requirement of PET bottles and polyester film • Ethyl / Butyl glycol ethers and its ace
Slide 26: Growth Drivers
Growth Drivers High prospects of growth of industry sectors being serviced by IGL – Personal Care, Automotive, Packaging, Beverages, Oil & Gas, Home Care, Pharma, Nutraceuticals etc, Textiles – most expected to grow at near double digit or more Increasing consumer awareness and demand for sustai
Slide 27: Yearly financial Performance
Yearly financial Performance
Slide 28: 3-year Financial Trajectory - Consolidated
3-year Financial Trajectory - Consolidated In INR Cr Net Revenue (Excl. Discontinued Biz.) EBITDA (Excl. Discontinued Biz.) PAT (Excl. Discontinued Biz.) 330 2,744 2,890 288 283 277 2,332 109 75 FY2020 FY2021 FY2022 FY2020 FY2021 FY2022 FY2020 FY2021 FY2022 EBITDA (Incl. Discontinued Biz.) PAT (Incl
Slide 29: 3-year Financial Trajectory - Consolidated
3-year Financial Trajectory - Consolidated EBITDA Margin (%) (Excl. Discontinued Biz.) Net Margin (%) (Excl. Discontinued Biz.) RoE (%) 11.4% 12.1% 10.5% 19.2% 9.6% 4.7% 11.1% 11.3% 2.7% FY2020 FY2021 FY2022 FY2020 FY2021 FY2022 FY2020 FY2021 FY2022 EBITDA Margin (%) (Incl. Discontinued Biz.) PAT Ma
Slide 30: Sustainability, ESG and Certifications
Sustainability, ESG and Certifications
Slide 31: Sustainability, ESG
Sustainability, ESG Environment Stewardship • World’s first and largest producer of Bio-Based EO and its derivatives • Next Generation CarbonSmart products from emissions (fossil carbon) - collaboration with Transparent Accountable LanzaTech & consumer majors like Unilever and Lululemon • Environmen
Slide 32: Thank you
India Glycols Limited EY LLP CIN: L24111UR1983PLC009097 Runjhun Jain Ankur Jain runjhun.jain1@in.ey.com Company Secretary & Compliance Officer Neha S Shroff neha.shroff@in.ey.com Head office 2B, Sector-126, Noida Rohit Anand Gautam Budh Nagar rohit.anand4@in.ey.com Uttar Pradesh 201304 Tel: +91-120-